Prof. Dr. Sergi X. Trilla, MD, MBA

Prof. Dr. Sergi X. Trilla,
MD, MBA

Physician. Founder and CEO of trifermed.

My work began in medicine and developed through health industry leadership, entrepreneurship, teaching, investment and initiatives for Social Impact in Health.

Across these settings, my interest has remained the same: how can better understanding, decisions and collaboration contribute to better health?

In 2002, I founded trifermed with Marta Fernández. The company’s story and my own have developed together, shaped by the people and organisations with whom we have worked.

A perspective grounded in medicine.

My earliest clinical experience began while studying medicine in the late 1980s. Training and subsequent practice in Spain and the United Kingdom brought me close to decisions with direct consequences for people.

The Hippocratic commitment continues to inspire my work: bringing knowledge, experience and judgement into the service of those we seek to help.

PeriodOrganisationExperience
1991–1994Clínica del Pilar BarcelonaObstetrics and gynaecology trainee while studying medicine
Sep 1994–Sep 1996Hospital de BarcelonaEmergency care
Jun 1995–Sep 1996RACCInternational medical emergency coordination
Sep 1996–Sep 1997NHS BirminghamSenior House Officer in obstetrics and gynaecology
Sep 1997–Jun 1998RACCInternational medical emergency coordination

Working across hospital care and international medical assistance helped shape my understanding of responsibility, uncertainty and the practical conditions needed to care for people.

Experience inside health organisations.

My move into the pharmaceutical industry connected clinical experience with the organisational and commercial decisions that shape whether innovations can reach people.

International marketing, business development and executive responsibilities have exposed me to different stages of company development, from emerging biotechnology ventures to established and publicly listed organisations.

PeriodOrganisationRole
Jun 1998–Jun 1999SanofiHead of Medical Marketing Line
Jun 1999–Jun 2002FerrerInternational Marketing Director
Jun 2002–presenttrifermedFounder and CEO
May 2020–Oct 2024HIPRASenior Business Strategy Advisor Human Health Division
Jul 2021–Oct 2022Intrommune TherapeuticsSenior Strategic Partnerships Advisor (Jul–Oct 2021) · Chief Strategy Officer (Nov 2021–Oct 2022)
May 2022–Apr 2025Veru Inc.Chief Business Officer
Feb 2024–Jul 2026MediscaSenior Business Strategy Advisor

Building trifermed.

I founded trifermed with Marta Fernández in 2002, following my experience in medicine and the pharmaceutical industry.

Over the years, our work has developed through international collaborations and the contributions of a team bringing different experience and perspectives to each decision. My own executive and advisory responsibilities have continued to inform that work.

Learning through teaching and mentoring.

Teaching and mentoring bring me into contact with different questions and ways of thinking. They allow me to share experience while continuing to challenge my own understanding.

PeriodInstitutionContribution
Sep 2008–Jun 2012BiocatTeaching in business development for health solutions
Feb 2012–Dec 2021ESADE Business SchoolAdjunct Professor Entrepreneurship in Health
May 2020–presentADA Forsyth InstituteAdjunct Faculty Entrepreneurship in Health
2020–presentUniversidad de NavarraVisiting Professor, Pharmaceutical and Biotechnology Management Master’s Programme
2013–presentBiocat d·Health BarcelonaAdvisor and contributor: programme formation and subsequent contributions
2026–presentCreative Destruction LabSan Sebastián: Mentor, Quantum and AI Stream · Doha: Health Mentor

An investor and evaluator perspective.

Working with investment communities and innovation programmes adds another perspective to the decisions founders and organisations face: what deserves commitment, what evidence is needed and what conditions can support progress.

PeriodOrganisationContribution
Jan 2024–presentNewHealth VenturesInvestment committee Digital Health
Oct 2025–presentMedex PartnersInvestor and Strategic Advisor
Feb 2026–presentFundación la Caixa CaixaImpulseExpert Evaluator Health Innovation

Initiatives and commitments.

The commitment that began in medicine has found expression through initiatives I have helped create and organisations whose work I support.

The EIRA Movement

Founder & Steward. A journey beginning in 2005.

I initiated the Trifermed Social Evening in 2005, creating a space for people connected to health, entrepreneurship and society. The Trifermed Awards followed in 2015, recognising people and organisations contributing to Social Impact in Health.

EIRA carries this history forward as a philanthropic, social-impact and catalytic movement associated with trifermed, through Knowledge, Recognition and Community.

Explore the EIRA Movement (external site, opens in a new tab)

Fundació d’Oncologia Infantil Enriqueta Villavecchia

Ambassador · Since November 2022.

The foundation supports children and young people with serious illness and their families. My commitment as an ambassador followed its recognition at the Trifermed Awards in September 2022.

Discover the foundation (external site, opens in a new tab)

Sharing experience through dialogue.

I contribute to conferences, teaching sessions and public conversations about health innovation, strategic decisions and collaboration.

YearSelected contribution
2013CPhI Worldwide Frankfurt — partnerships in animal health; One Nucleus London — analysis for partnering
2014MaRS Discovery District Toronto — partnerships for healthcare start-ups; Klifovet Munich — business modelling for veterinary medicinal products
2014Bioemprenedor XXI Barcelona — partnering project methodology
2015BIO KOREA — business modelling before partnering; Lessons Learned CataloniaBio and Biocat
2026CPHI Milan — interview and public dialogue on health innovation

Selected invited contributions also include Weill Cornell Medicine Qatar, HEC Paris, Northeastern University, UAB, UAM and other scientific and business programmes.

Education

  • Medicine and Surgery

    Universitat Autònoma de Barcelona

    1988–1994

  • MBA

    Universitat de Barcelona

    1997–1999

  • Artificial Intelligence: Implications for Business Strategy

    MIT Sloan Executive Education and CSAIL

    2024

Observations from Three Decades in Healthcare Innovation

The questions and lessons from this work are taking shape through essays and Strategic Case Essays, forming the foundations of a book.

Continue the conversation.

If your work raises a strategic question in health innovation, I would be pleased to hear from you.

Let’s talk